Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Nature Reviews Immunology (2020) https://doi.org/10.1038/s41577-020-0331-4 Published online 06 May 2020

In the originally published article, the imprecise wording of a sentence implied that IL-6 blockade had been approved by the FDA for treatment of COVID-19. This has now been corrected in the HTML and PDF versions of the article to clarify that the FDA had, at the time of writing, only approved trials of IL-6 blockade in patients with COVID-19.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Miriam Merad or Jerome C. Martin.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Merad, M., Martin, J.C. Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20, 448 (2020). https://doi.org/10.1038/s41577-020-0353-y

Download citation